Table 4.
Univariate b | Multivariate c | Multivariate d | ||||||
---|---|---|---|---|---|---|---|---|
Maternal Variables | Time-Point | n | β (SE) | p-Value | β (SE) | p-Value | β (SE) | p-Value |
Serum vitamin B12,a pmol/L | Mid-gestation | 51 | −0.04 (0.16) | 0.79 | −0.19 (0.14) | 0.17 | −0.16 (0.13) | 0.22 |
Delivery (All) | 61 | −0.02 (0.11) | 0.88 | −0.08 (0.11) | 0.48 | −0.08 (0.11) | 0.45 | |
Delivery (Recruited at mid-gestation) | 30 | −0.20 (0.15) | 0.18 | −0.20 (0.13) | 0.13 | −0.22 (0.12) | 0.07 | |
Delivery (Recruited at delivery) | 31 | 0.14 (0.16) | 0.37 | 0.04 (0.15) | 0.78 | 0.06 (0.15) | 0.67 | |
<148.0 pmol/L | Mid-gestation | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
Delivery (All) | 61 | 0.07 (0.13) | 0.60 | 0.16 (0.12) | 0.16 | 0.18 (0.12) | 0.14 | |
Delivery (Recruited at mid-gestation) | 30 | 0.26 (0.17) | 0.13 | 0.26 (0.14) | 0.07 | 0.38 (0.13) | 0.005 | |
Delivery (Recruited at delivery) | 31 | −0.10 (0.18) | 0.57 | 0.07 (0.17) | 0.65 | 0.03 (0.17) | 0.88 | |
<221.0 pmol/L | Mid-gestation | 51 | −0.05 (0.14) | 0.71 | 0.01 (0.13) | 0.91 | 0.07 (0.12) | 0.54 |
Delivery (All) | 61 | −0.01 (0.09) | 0.90 | 0.05 (0.09) | 0.58 | 0.07 (0.09) | 0.47 | |
Delivery (Recruited at mid-gestation) | 30 | 0.18 (0.12) | 0.12 | 0.22 (0.11) | 0.04 | 0.27 (0.10) | 0.006 | |
Delivery (Recruited at delivery) | 31 | −0.19 (0.13) | 0.15 | −0.09 (0.12) | 0.45 | −0.12 (0.13) | 0.37 | |
Serum folate a, nmol/L | Mid-gestation | 50 | 0.27 (0.14) | 0.06 | 0.05 (0.13) | 0.69 | 0.003 (0.13) | 0.98 |
Delivery (All) | 61 | 0.54 (0.09) | <0.0001 | 0.47 (0.10) | <0.0001 | 0.50 (0.10) | <0.0001 | |
Delivery (Recruited at mid-gestation) | 30 | 0.54 (0.11) | <0.0001 | 0.55 (0.13) | <0.001 | 0.53 (0.15) | 0.0003 | |
Delivery (Recruited at delivery) | 31 | 0.57 (0.13) | <0.0001 | 0.45 (0.13) | 0.0005 | 0.44 (0.12) | 0.0003 | |
<40.0 nmol/L | Mid-gestation | 50 | −0.25 (0.12) | 0.03 | −0.13 (0.10) | 0.21 | −0.09 (0.10) | 0.39 |
Delivery (All) | 61 | −0.42 (0.08) | <0.0001 | −0.40 (0.08) | <0.0001 | −0.42 (0.08) | <0.0001 | |
Delivery (Recruited at mid-gestation) | 30 | −0.44 (0.09) | <0.0001 | −0.43 (0.10) | <0.0001 | −0.51 (0.12) | <0.0001 | |
Delivery (Recruited at delivery) | 31 | −0.41 (0.12) | 0.0006 | −0.32 (0.12) | 0.01 | −0.33 (0.12) | 0.006 |
a Statistical analyses: linear regression models were used to examine associations between maternal vitamin B12 and folate status and infant serum vitamin B12 concentrations; vitamin B12 and folate concentrations were natural logarithmically transformed prior to analyses; b Adjusted for gestational age of sample collection; c Adjusted for gestational age of sample collection, maternal age at delivery, parity (≥1 vs. 0), ever smoked (yes vs. no), relationship status (single vs. married/in a relationship), self-reported prenatal supplement use (≥2 vs. <2 pills/week), pre-pregnancy BMI, and race (African American vs. other); d Adjusted for gestational age of sample collection, maternal age at delivery, parity (≥1 vs. 0), ever smoked (yes vs. no), relationship status (single vs. married/in a relationship), self-reported prenatal supplement use (≥2 vs. <2 pills/week), pre-pregnancy BMI, race (African American vs. other), intake of vitamin B12, and intake of folate